DTB Republished case report: Unintentional overdose of hyoscine hydrobromide in a young child

Based on a case in a 4-year-old child, clinicians are advised to be aware of unintentional ingestions in children which may present with psychiatric manifestations. To mitigate risk, since hyoscine hydrobromide is available OTC, the authors call for a more childproof container.

Source:

Drug and Therapeutics Bulletin